Liquidia Technologies (LQDA) Projected to Post Quarterly Earnings on Wednesday

Key Points

• Liquidia Technologies is expected to report quarterly earnings on August 6th, with analysts predicting a loss of ($0.43) per share and revenue of $3.90 million.
• The company reported a net margin of -903.80% and a negative return on equity of -177.91% in the last quarter, with earnings missing expectations.
• Insider trading showed CEO Roger Jeffs selling shares, resulting in a 1.91% decrease in his position, while corporate insiders own 30.10% of the company's stock.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) is expected to announce its Q2 2025 earnings results before the market opens on Wednesday, August 6th. Analysts expect Liquidia Technologies to post earnings of ($0.43) per share and revenue of $3.90 million for the quarter.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). Liquidia Technologies had a negative net margin of 903.80% and a negative return on equity of 177.91%. The firm had revenue of $3.12 million during the quarter, compared to analyst estimates of $3.23 million. On average, analysts expect Liquidia Technologies to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Liquidia Technologies Stock Performance

Shares of Liquidia Technologies stock traded down $0.04 on Friday, reaching $18.65. 191,394 shares of the stock were exchanged, compared to its average volume of 1,608,706. The business has a 50 day moving average price of $15.00 and a two-hundred day moving average price of $14.83. The firm has a market capitalization of $1.59 billion, a price-to-earnings ratio of -11.83 and a beta of -0.01. Liquidia Technologies has a twelve month low of $8.26 and a twelve month high of $20.33. The company has a quick ratio of 2.91, a current ratio of 2.93 and a debt-to-equity ratio of 2.08.

Insider Activity

In other Liquidia Technologies news, insider Rajeev Saggar sold 5,327 shares of Liquidia Technologies stock in a transaction on Monday, July 14th. The shares were sold at an average price of $14.28, for a total transaction of $76,069.56. Following the sale, the insider owned 271,413 shares of the company's stock, valued at $3,875,777.64. The trade was a 1.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Roger Jeffs sold 20,252 shares of the firm's stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $289,198.56. Following the completion of the transaction, the chief executive officer directly owned 1,038,560 shares in the company, valued at approximately $14,830,636.80. This represents a 1.91% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 60,277 shares of company stock worth $869,392. Company insiders own 26.50% of the company's stock.

Institutional Investors Weigh In On Liquidia Technologies

A number of large investors have recently made changes to their positions in LQDA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Liquidia Technologies by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company's stock worth $556,000 after buying an additional 1,700 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Liquidia Technologies by 10.7% during the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company's stock worth $12,703,000 after purchasing an additional 82,955 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Liquidia Technologies by 15.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company's stock valued at $1,796,000 after purchasing an additional 16,022 shares during the last quarter. 64.54% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on LQDA shares. Bank of America decreased their price objective on shares of Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Wednesday, June 11th. Wells Fargo & Company raised their target price on shares of Liquidia Technologies from $23.00 to $25.00 and gave the stock an "overweight" rating in a report on Thursday, June 12th. BTIG Research reaffirmed a "buy" rating on shares of Liquidia Technologies in a report on Tuesday, May 27th. Oppenheimer set a $13.00 price target on Liquidia Technologies and gave the stock an "underperform" rating in a research report on Monday, May 19th. Finally, Wall Street Zen raised Liquidia Technologies from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $26.89.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).